Your browser doesn't support javascript.
loading
Association of Vedolizumab Level, Anti-Drug Antibodies, and α4ß7 Occupancy With Response in Patients With Inflammatory Bowel Diseases.
Ungar, Bella; Kopylov, Uri; Yavzori, Miri; Fudim, Ella; Picard, Orit; Lahat, Adi; Coscas, Daniel; Waterman, Matti; Haj-Natour, Ola; Orbach-Zingboim, Noam; Mao, Ren; Chen, Minhu; Chowers, Yehuda; Eliakim, Rami; Ben-Horin, Shomron.
Afiliação
  • Ungar B; Department of Gastroenterology, Sheba Medical Center Tel Hashomer, Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel. Electronic address: bellageyshis@gmail.com.
  • Kopylov U; Department of Gastroenterology, Sheba Medical Center Tel Hashomer, Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Yavzori M; Department of Gastroenterology, Sheba Medical Center Tel Hashomer, Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Fudim E; Department of Gastroenterology, Sheba Medical Center Tel Hashomer, Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Picard O; Department of Gastroenterology, Sheba Medical Center Tel Hashomer, Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Lahat A; Department of Gastroenterology, Sheba Medical Center Tel Hashomer, Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Coscas D; Department of Gastroenterology, Sheba Medical Center Tel Hashomer, Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Waterman M; Rambam Health Care Campus, Bruce and Ruth Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Haj-Natour O; Department of Gastroenterology, Sheba Medical Center Tel Hashomer, Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Orbach-Zingboim N; Department of Gastroenterology, Sheba Medical Center Tel Hashomer, Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Mao R; The First Affiliated Hospital of Sun-Yatsen University, Guangzhou, China.
  • Chen M; The First Affiliated Hospital of Sun-Yatsen University, Guangzhou, China.
  • Chowers Y; Rambam Health Care Campus, Bruce and Ruth Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Eliakim R; Department of Gastroenterology, Sheba Medical Center Tel Hashomer, Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Ben-Horin S; Department of Gastroenterology, Sheba Medical Center Tel Hashomer, Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel; The First Affiliated Hospital of Sun-Yatsen University, Guangzhou, China.
Clin Gastroenterol Hepatol ; 16(5): 697-705.e7, 2018 05.
Article em En | MEDLINE | ID: mdl-29223444
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Doenças Inflamatórias Intestinais / Integrinas / Anticorpos Monoclonais Humanizados / Anticorpos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Animals / Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Doenças Inflamatórias Intestinais / Integrinas / Anticorpos Monoclonais Humanizados / Anticorpos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Animals / Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2018 Tipo de documento: Article